These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16250660)
21. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides. Shmalenyuk ER; Chernousova LN; Karpenko IL; Kochetkov SN; Smirnova TG; Andreevskaya SN; Chizhov AO; Efremenkova OV; Alexandrova LA Bioorg Med Chem; 2013 Sep; 21(17):4874-84. PubMed ID: 23891229 [TBL] [Abstract][Full Text] [Related]
22. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain. McGuigan C; Barucki H; Carangio A; Blewett S; Andrei G; Snoeck R; De Clercq E; Balzarini J; Erichsen JT J Med Chem; 2000 Dec; 43(26):4993-7. PubMed ID: 11150169 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides. Janeba Z; Balzarini J; Andrei G; Snoeck R; De Clercq E; Robins MJ J Med Chem; 2005 Jul; 48(14):4690-6. PubMed ID: 16000005 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and antimycobacterial activities of ring-substituted quinolinecarboxylic acid/ester analogues. Part 1. Vaitilingam B; Nayyar A; Palde PB; Monga V; Jain R; Kaur S; Singh PP Bioorg Med Chem; 2004 Aug; 12(15):4179-88. PubMed ID: 15246094 [TBL] [Abstract][Full Text] [Related]
25. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity. Alvey L; Prado S; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL Eur J Med Chem; 2009 Jun; 44(6):2497-505. PubMed ID: 19232450 [TBL] [Abstract][Full Text] [Related]
26. Incorporation of 5-substituted pyrimidine nucleoside analogues into DNA of a thymidylate synthetase-deficient murine FM3A carcinoma cell line. Balzarini J; De Clercq E; Ayusawa D; Seno T Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):19-28. PubMed ID: 3990443 [TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus. Kumar R; Nath M; Tyrrell DL J Med Chem; 2002 May; 45(10):2032-40. PubMed ID: 11985471 [TBL] [Abstract][Full Text] [Related]
28. Pyrrolo[2,3-d]pyrimidine nucleosides: synthesis and antitumor activity of 7-substituted 7-deaza-2'-deoxyadenosines. Seela F; Zulauf M; Chen SF Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):237-51. PubMed ID: 10772712 [TBL] [Abstract][Full Text] [Related]
30. Investigation of C-5 alkynyl (alkynyloxy or hydroxymethyl) and/or N-3 propynyl substituted pyrimidine nucleoside analogs as a new class of antimicrobial agents. Garg S; Shakya N; Srivastav NC; Agrawal B; Kunimoto DY; Kumar R Bioorg Med Chem; 2016 Nov; 24(21):5521-5533. PubMed ID: 27665179 [TBL] [Abstract][Full Text] [Related]
31. Discovery of a new family of inhibitors of human cytomegalovirus (HCMV) based upon lipophilic alkyl furano pyrimidine dideoxy nucleosides: action via a novel non-nucleosidic mechanism. McGuigan C; Pathirana RN; Snoeck R; Andrei G; De Clercq E; Balzarini J J Med Chem; 2004 Mar; 47(7):1847-51. PubMed ID: 15027877 [TBL] [Abstract][Full Text] [Related]
32. Bicyclic nucleoside inhibitors of varicella-zoster virus: effect of terminal aryl substitution in the side-chain. Carangio A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J Antivir Chem Chemother; 2002 Sep; 13(5):263-71. PubMed ID: 12630674 [TBL] [Abstract][Full Text] [Related]
33. Relationship between the structure and antimycobacterial activity of substituted salicylanilides. Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254 [TBL] [Abstract][Full Text] [Related]
34. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
35. Ring-substituted quinolines. Part 2: Synthesis and antimycobacterial activities of ring-substituted quinolinecarbohydrazide and ring-substituted quinolinecarboxamide analogues. Monga V; Nayyar A; Vaitilingam B; Palde PB; Jhamb SS; Kaur S; Singh PP; Jain R Bioorg Med Chem; 2004 Dec; 12(24):6465-72. PubMed ID: 15556764 [TBL] [Abstract][Full Text] [Related]
36. Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro. Torrence PF; Fan X; Zhang X; Loiseau PM Bioorg Med Chem Lett; 2006 Oct; 16(19):5047-51. PubMed ID: 16879965 [TBL] [Abstract][Full Text] [Related]
37. Sedative and hypnotic activities of pyrimidine nucleoside derivatives. Kimura T; Teraoka S; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I Nucleic Acids Symp Ser; 1993; (29):51-2. PubMed ID: 8247791 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and in vitro antimycobacterial activity of balofloxacin ethylene isatin derivatives. Feng LS; Liu ML; Wang B; Chai Y; Hao XQ; Meng S; Guo HY Eur J Med Chem; 2010 Aug; 45(8):3407-12. PubMed ID: 20493593 [TBL] [Abstract][Full Text] [Related]
39. A novel class of potent influenza virus inhibitors: polysubstituted acylthiourea and its fused heterocycle derivatives. Sun C; Huang H; Feng M; Shi X; Zhang X; Zhou P Bioorg Med Chem Lett; 2006 Jan; 16(1):162-6. PubMed ID: 16216505 [TBL] [Abstract][Full Text] [Related]
40. Novel semisynthetic antibiotics from caprazamycins A-G: caprazene derivatives and their antibacterial activity. Takahashi Y; Igarashi M; Miyake T; Soutome H; Ishikawa K; Komatsuki Y; Koyama Y; Nakagawa N; Hattori S; Inoue K; Doi N; Akamatsu Y J Antibiot (Tokyo); 2013 Mar; 66(3):171-8. PubMed ID: 23532021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]